Evidence map›Paper›PMID 35531955›Full record

ArticleJCI insight2022

Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell-specific manner.

Alan Avalos, Jacob T Tietsort, Nutthakarn Suwankitwat, Jonathan D Woods, Shaun W Jackson, Alexandra Christodoulou, Christopher Morrill, H Denny Liggitt, Chengsong Zhu, Quan-Zhen Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia-Reperfusion Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Alan AvalosThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Jacob T TietsortThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Nutthakarn SuwankitwatThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Jonathan D WoodsSeattle Children's Research Institute, Seattle, Washington, USA.
Shaun W JacksonSeattle Children's Research Institute, Seattle, Washington, USA.
Alexandra ChristodoulouThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Christopher MorrillThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
H Denny LiggittThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Chengsong ZhuDepartment of Immunology, Microarray and Immune Phenotyping Core Facility, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Quan-Zhen LiDepartment of Immunology, Microarray and Immune Phenotyping Core Facility, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kevin K BuiThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Heon ParkThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Brian M IritaniThe Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
University of Washington · USThe University of Texas Southwestern Medical Center · US

Funding

WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunityR01AI158353 · NIAID · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2021 to 2025
$2.8M
Targeting Fnip1 to disrupt B cell development, metabolism, and transformationR01AI114556 · NIAID · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2015 to 2019
$2.0M
Dissecting Hem-1 functions in B lymphocyte Development and Primary Immunodeficiency DiseaseR21AI156243 · NIAID · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2021 to 2022
$428k
Folliculin Interacting Proteins in Lymphocyte Development and AutoimmunityR21AI109020 · NIAID · UNIVERSITY OF WASHINGTON · PI IRITANI, BRIAN M · 2014 to 2015
$425k
NIAID NIH HHS R01 AI114556NIAID NIH HHS R01 AI158353NIAID NIH HHS R21 AI109020NIAID NIH HHS R21 AI156243
6 · The paper itself

Abstract

Hematopoietic protein-1 (Hem-1) is a member of the actin-regulatory WASp family verprolin homolog (WAVE) complex. Loss-of-function variants in the NCKAP1L gene encoding Hem-1 were recently discovered to result in primary immunodeficiency disease (PID) in children, characterized by poor specific Ab responses, increased autoantibodies, and high mortality. However, the mechanisms of how Hem-1 deficiency results in PID are unclear. In this study, we utilized constitutive and B cell-specific Nckap1l-KO mice to dissect the importance of Hem-1 in B cell development and functions. B cell-specific disruption of Hem-1 resulted in reduced numbers of recirculating follicular (FO), marginal zone (MZ), and B1 B cells. B cell migration in response to CXCL12 and -13 were reduced. T-independent Ab responses were nearly abolished, resulting in failed protective immunity to Streptococcus pneumoniae challenge. In contrast, T-dependent IgM and IgG2c, memory B cell, and plasma cell responses were more robust relative to WT control mice. B cell-specific Hem-1-deficient mice had increased autoantibodies against multiple autoantigens, and this correlated with hyperresponsive BCR signaling and increased representation of CD11c+T-bet+ age-associated B cell (ABC cells) - alterations associated with autoimmune diseases. These results suggest that dysfunctional B cells may be part of a mechanism explaining why loss-of-function Hem-1 variants result in recurring infections and autoimmunity.

Indexed as

Adaptor Proteins, Signal TransducingAutoantibodiesAutoimmune DiseasesB-LymphocytesImmunity, HumoralActinsAnimalsMiceMice, KnockoutActinsAdaptor Proteins, Signal TransducingAutoantibodiesHem1 protein, mouseAutoimmune diseasesBacterial infectionsCytoskeletonImmunology

Identifiers

PMID35531955
PMCPMC9090261
OpenAlexW4229333698

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.